Literature DB >> 17352341

Perivascular spaces: normal and giant.

Randy Fanous1, Mehran Midia.   

Abstract

The purpose of this paper is to discuss both normal perivascular spaces (PVSs) and pathological giant perivascular spaces (GPVSs). The anatomy and physiology of normal PVSs, including important immunological and lymphatic roles, are described. Special attention is given to the Magnetic Resonance Imaging (MRI) findings of both normal and GPVSs. Furthermore, the clinical features and pathogenesis of GPVSs are explored, with special emphasis on the pathological implications of these lesions, and their relevance. It is important that symptomatic GPVSs not be mistaken for more devastating disease processes. When the lesions in question occur in a characteristic location along the path of a penetrating vessel, are isointense with cerebrospinal fluid on all MRI sequences, do not enhance with contrast material, are not calcified, and have normal adjacent brain parenchyma, their appearance is pathognomonic of GPVSs. The clinician should realize that an extensive differential diagnosis is superfluous and that biopsy is unnecessary in these patients. Instead, the clinical focus should be aimed at neurosurgical intervention, as dictated by the symptoms of mass effect.

Entities:  

Mesh:

Year:  2007        PMID: 17352341     DOI: 10.1017/s0317167100005722

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  10 in total

1.  Linear sign in cystic brain lesions ≥5 mm: A suggestive feature of perivascular space.

Authors:  Jinkyeong Sung; Jinhee Jang; Hyun Seok Choi; So-Lyung Jung; Kook-Jin Ahn; Bum-Soo Kim
Journal:  Eur Radiol       Date:  2017-05-24       Impact factor: 5.315

2.  Spontaneous regression and recurrence of a tumefactive perivascular space.

Authors:  Thomas Jose Eluvathingal Muttikkal; Prashant Raghavan
Journal:  Neuroradiol J       Date:  2014-04-18

3.  Giant tumefactive perivascular spaces: A case report.

Authors:  Keith Freeman; Richard Hays; Joshua Kouri
Journal:  Surg Neurol Int       Date:  2020-07-18

4.  Regression of dilated perivascular spaces of the brain.

Authors:  Alfonso Cerase; Ignazio Maria Vallone; Carmine Franco Muccio; Carlo Petrini; Giorgio Signori; Carlo Venturi
Journal:  Surg Radiol Anat       Date:  2009-12-03       Impact factor: 1.246

5.  Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study.

Authors:  Renata Conforti; Mario Cirillo; Pietro Paolo Saturnino; Antonio Gallo; Rosaria Sacco; Alberto Negro; Antonella Paccone; Giuseppina Caiazzo; Alvino Bisecco; Simona Bonavita; Sossio Cirillo
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

6.  Dilated Virchow-Robin space and Parkinson's disease: A case report of combined MRI and diffusion tensor imaging.

Authors:  Renata Conforti; Angela Sardaro; Alberto Negro; Giuseppina Caiazzo; Antonella Paccone; Rosita De Micco; Sossio Cirillo; Alessandro Tessitore
Journal:  Radiol Case Rep       Date:  2018-06-30

7.  Symptomatic Giant Virchow-Robin Spaces: A Rare Cause of Spastic Quadriparesis in 43-Year-old Ethiopian Patient: A Case Report.

Authors:  Biniyam Ayele; Guta Zenebe; Abenet Mengesha; Yegeta Teshale
Journal:  Ethiop J Health Sci       Date:  2020-09

Review 8.  Spontaneous regression of asymptomatic tumefactive perivascular spaces in the anterior temporal lobe.

Authors:  Miki Hashida; Yoshitaka Nagashima; Yusuke Nishimura; Kaoru Eguchi; Toshiaki Taoka; Hisashi Kawai; Ryuta Saito
Journal:  Nagoya J Med Sci       Date:  2022-08       Impact factor: 0.794

9.  Giant tumefactive perivascular spaces that expanded and became symptomatic 14 years after initial surgery.

Authors:  Kenji Fujimoto; Jun-Ichiro Kuroda; Takuichiro Hide; Yu Hasegawa; Shigetoshi Yano; Jun-Ichi Kuratsu
Journal:  Surg Neurol Int       Date:  2012-10-27

10.  Giant tumefactive perivascular spaces: A further case.

Authors:  Senthilkumar Sankararaman; Sujithra Velayuthan; Sudheer Ambekar; Eduardo Gonzalez-Toledo
Journal:  J Pediatr Neurosci       Date:  2013-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.